cbdMD, Inc.YCBDNYSE
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-8.0%/yr
vs -21.2%/yr prior
Acceleration
+13.1pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 52.69% |
| Q3 2025 | 63.67% |
| Q2 2025 | 27.59% |
| Q1 2025 | -31.82% |
| Q4 2024 | 18.52% |
| Q3 2024 | -80.00% |
| Q2 2024 | 88.89% |
| Q1 2024 | -101.49% |
| Q4 2023 | 88.25% |
| Q3 2023 | -391.38% |
| Q2 2023 | 33.33% |
| Q1 2023 | 52.97% |
| Q4 2022 | 67.74% |
| Q3 2022 | 53.68% |
| Q2 2022 | -473.15% |
| Q1 2022 | 71.93% |
| Q4 2021 | -351.32% |
| Q3 2021 | -537.18% |
| Q2 2021 | 107.51% |
| Q1 2021 | -26.59% |
| Q4 2020 | -49.36% |
| Q3 2020 | 30.86% |
| Q2 2020 | -160.84% |
| Q1 2020 | -28.41% |
| Q4 2019 | -12.98% |
| Q3 2019 | 146.71% |
| Q2 2019 | 27.29% |
| Q1 2019 | -553.39% |
| Q4 2018 | -137.19% |
| Q3 2018 | -434.45% |
| Q2 2018 | -84.80% |
| Q1 2018 | 223.50% |
| Q4 2017 | -188.18% |
| Q3 2017 | -8.91% |
| Q2 2017 | 62.10% |
| Q1 2017 | 12.48% |
| Q4 2016 | 38.55% |
| Q3 2016 | 14.42% |
| Q2 2016 | 0.00% |